Latest News

Shark Mitigation Systems Limited (SM8.AX) Limping -36.00% For the Quarter

Shark Mitigation Systems Limited (SM8.AX) has ended the quarter in the red, yielding negative results for the shares at they ticked -36.00% over that time frame. In taking a look at recent performance, we can see that shares have moved -5.88% over the past 4-weeks, -48.39% over the past half year and -52.94% over the past full year. Shark Mitigation Systems Limited ‘s weekly performance […]

Crown Holdings, Inc. (NYSE:CCK) Short Interest Update as Shares take Spotlight

According to the latest stock data, investors are looking at Crown Holdings, Inc. (NYSE:CCK)’s short data and trying to figure out market sentiment on which way the market thinks the stock is moving. The firm has 9.26% of total shares float short, yielding a short ratio of 7.41. Top notch investors are usually adept at filtering through the constant financial headlines. Now more than ever, […]

Baytex Energy Corp. (TSX:BTE) versus Lindsay Corporation (NYSE:LNN) Technicals Update: A Look Under the Hood

Baytex Energy Corp. (TSX:BTE) currently has a Value Composite score of 16.  Similarly, the Value Composite Two (VC2) is calculated with the same ratios, but adds the Shareholder Yield.  The Value Composite Two of Baytex Energy Corp. (TSX:BTE) is 34. Under recent market conditions, it may be quite difficult to be overly bearish. Most signs seem to be pointing in the […]

Australian Ethical Investment Ltd (ASX:AEF) According to Quant Should HOld 0.03760 of An Investor’s Portfolio

A recent look at ownership and volatility brings us to a 0.03760 target portfolio weight (as a decimal) for Australian Ethical Investment Ltd (ASX:AEF) Target weight is the volatility adjusted recommended stock position size for a position in your portfolio.  The maximum target weight is 7% for any given stock.  The indicator is based off of the 100 day volatility reading and calculates […]

Investor Survey: Target Price in Focus on Shares of FibroGen, Inc (NASDAQ:FGEN)

After a recent review, we have noted that shares of FibroGen, Inc (NASDAQ:FGEN) have an average target price of $76.25. This is the consensus target price provided by analysts used by Zacks Research. Professional sell-side analysts that cover the stock are usually diligently monitoring the company to gauge future stock price movements. Price target projections can be calculated using alternate […]